Small molecule-switchable RNA platform enables control of therapeutic protein expression

FHS
January 2, 2024
11:27 am

Just like a doctor adjusts the dose of a medication to the patient’s needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window.

Aspirin Outcomes No Different With Safety Coating

An enteric coating did not hurt the effectiveness of aspirin pills for secondary prevention of atherosclerotic cardiovascular disease (ASCVD), but it didn’t make it any

October 5, 2023

Return of the megarounds; Nvidia’s AI pitch to biotech; Bayer’s shakeup reaches the top; AstraZeneca buys into radiopharma; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

March 24, 2024

Biotech accelerator Blackbird Labs launches with $100m grant – Pharmaceutical Technology

The initial focus of the organisation is on inflammation and immunology, neurological diseases, genetic diseases, and cancer. Credit: PeopleImages via Getty Images. New life sciences

November 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.